154 related articles for article (PubMed ID: 29616582)
1. Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
Suzuki A; Sakai Y; Hashimoto K; Osawa H; Tsuruoka S
Ren Fail; 2018 Nov; 40(1):196-200. PubMed ID: 29616582
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
3. L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.
Csiky B; Nyul Z; Tóth G; Wittmann I; Melegh B; Rauh M; Rascher W; Sulyok E
Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):735-40. PubMed ID: 20658442
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients.
Alhomida AS
Arch Med Res; 1997; 28(1):101-7. PubMed ID: 9078596
[TBL] [Abstract][Full Text] [Related]
5. Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.
Marín VB; Azocar M; Molina M; Guerrero JL; Ratner R; Cano F
Adv Perit Dial; 2006; 22():130-5. PubMed ID: 16983956
[TBL] [Abstract][Full Text] [Related]
6. L-carnitine supplementation and EPO requirement in children on chronic hemodialysis.
Aoun B; Bérard E; Vitkevic R; Dehée A; Bensman A; Ulinski T
Pediatr Nephrol; 2010 Mar; 25(3):557-60. PubMed ID: 19662438
[TBL] [Abstract][Full Text] [Related]
7. Carnitine action on red blood cell osmotic resistance in hemodialysis patients.
Vlassopoulos DA; Hadjiyannakos DK; Anogiatis AG; Evageliou AE; Santikou AV; Noussias CV; Papandreou PT; Hadjiconstantinou VE
J Nephrol; 2002; 15(1):68-73. PubMed ID: 11936429
[TBL] [Abstract][Full Text] [Related]
8. Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis.
Wanner C; Förstner-Wanner S; Schaeffer G; Schollmeyer P; Hörl WH
Am J Nephrol; 1986; 6(3):206-11. PubMed ID: 3740128
[TBL] [Abstract][Full Text] [Related]
9. Effects of L-carnitine supplementation on cardiac morbidity in hemodialyzed patients.
Matsumoto Y; Sato M; Ohashi H; Araki H; Tadokoro M; Osumi Y; Ito H; Morita H; Amano I
Am J Nephrol; 2000; 20(3):201-7. PubMed ID: 10878401
[TBL] [Abstract][Full Text] [Related]
10. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients.
Matsumura M; Hatakeyama S; Koni I; Mabuchi H; Muramoto H
Nephron; 1996; 72(4):574-8. PubMed ID: 8730424
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral L-carnitine on serum myoglobin in hemodialysis patients.
Feinfeld DA; Kurian P; Cheng JT; Dilimetin G; Arriola MR; Ward L; Manis T; Carvounis CP
Ren Fail; 1996 Jan; 18(1):91-6. PubMed ID: 8820505
[TBL] [Abstract][Full Text] [Related]
12. Accelerated recovery of post-dialysis plasma carnitine fall by oral carnitine.
Bizzi A; Mingardi G; Codegoni AM; Mecca G; Garattini S
Biomedicine; 1978 Oct; 29(6):183-4. PubMed ID: 737275
[TBL] [Abstract][Full Text] [Related]
13. Dialysis-related carnitine disorder and levocarnitine pharmacology.
Evans A
Am J Kidney Dis; 2003 Apr; 41(4 Suppl 4):S13-26. PubMed ID: 12751050
[TBL] [Abstract][Full Text] [Related]
14. [Levels of L-carnitine in serum of patients with chronic renal failure treated by hemodialysis (HD)].
Wanic-Kossowska M; Bombicki K; Kozioł L; Czarnecki R
Pol Arch Med Wewn; 1998 Apr; 99(4):314-22. PubMed ID: 9760819
[TBL] [Abstract][Full Text] [Related]
15. Effect of carnitine supplementation on cardiac function in hemodialyzed children.
Topaloğlu R; Celiker A; Saatçi U; Kilinç K; Bakkaloğlu A; Beşbaş N; Sezaözen ; Tokel K
Acta Paediatr Jpn; 1998 Feb; 40(1):26-9. PubMed ID: 9583196
[TBL] [Abstract][Full Text] [Related]
16. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
[TBL] [Abstract][Full Text] [Related]
17. Short-term effects of nocturnal haemodialysis on carnitine metabolism.
Hothi DK; Geary DF; Fisher L; Chan CT
Nephrol Dial Transplant; 2006 Sep; 21(9):2637-41. PubMed ID: 16822785
[TBL] [Abstract][Full Text] [Related]
18. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
Böhles H; Michalk D; von Wendt-Göknur E
Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
[TBL] [Abstract][Full Text] [Related]
19. [L-carnitine therapy and myocardial function in children treated with chronic hemodialysis].
Khoss AE; Steger H; Legenstein E; Proll E; Salzer-Muhar U; Schlemmer M; Balzar E; Wimmer M
Wien Klin Wochenschr; 1989 Jan; 101(1):17-20. PubMed ID: 2913722
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients.
Brass EP
Clin Ther; 1995; 17(2):176-85; discussion 175. PubMed ID: 7614519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
